Meridian's E. Coli Toxin Test Granted New Claim
go back to news archives Meridian Bioscience have announced that it has been granted FDA clearance to market an additional claim related to its ImmunoCard STAT!(R) E. coli O157 Plus. This test identifies the most dangerous Shiga toxin-producing E. coli bacteria that can cause severe kidney damage or death, especially in infected children under 5 years of age. This new claim will enable the toxin- producing E. coli O157 antigens to be detected from the most commonly used collection and transport culture medium, thereby reducing time and labor for the testing laboratory.
The first recognized U.S. outbreak of E. coli O157 was reported in 1982 and was associated with eating hamburgers from a particular fast-food chain. Since 1982, E. coli O157 outbreaks have occurred more frequently with approximately 13% of these due to food sources other than beef products. It is now estimated that, among children under 5 years of age, the incidence of infection can be as high as 6 per 100,000.
Source : Meridian Bioscience, Inc. View Company Information
Posted on January 24, 2003
LATEST MICROBIOLOGY NEWS
-
AOAC Validated iQ-Check Vibrio PCR Kit
01 Apr 2025 -
AI-Powered Precision For Colony Counting
27 Mar 2025
MICROBIOLOGY EVENTS
-
Mycotoxin Detection and Analysis: Strategies to Support Your Testing Program
3 Apr 2025 -
15th Conference of The World Mycotoxin Forum® – WMFmeetsSalzburg
7 Apr 2025 -
ESCMID European Congress of Clinical Microbiology and Infectious Diseases
11 Apr 2025 -
IBQC 2025
14 Apr 2025 -
IFU Technical Workshop 2025
15 Apr 2025 -
Validation of Water Systems for Microbial Control
23 Apr 2025 -
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
Free Expert Webinar: Advancing Drinking Water Microbiology Testing Compliance & Efficiency
29 Apr 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025